Molecular targeting for treatment of human T-lymphotropic virus type 1 infection

Molecular targeting for treatment of human T-lymphotropic virus type 1 infection

Human T-cell lymphotropic virus type 1 (HTLV-1) infection is linked to adult T-cell leukemia-lymphoma (ATLL) and HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and several other disorders. ATLL occurs in approximately 5% of the 15–20 million people infected by HTLV-1 in the worl...

Full description

Bibliographic Details
Main Authors: Arash Soltani, Seyed Isaac Hashemy, Farnaz Zahedi Avval, Anvar Soleimani, Houshang Rafatpanah, Seyed Abdorahim Rezaee, Renate Griffith, Baratali Mashkani
Format: Article
Language:English
Published: Elsevier 2019-01-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Human T-cell lymphotropic virus 1 (HTLV-1)
Adult T-cell leukemia-lymphoma (ATLL)
Antiviral therapy
Reverse transcriptase
Integrase
Protease
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332218354817

Internet

http://www.sciencedirect.com/science/article/pii/S0753332218354817

Similar Items